C12Y 101/0105
3alpha-hydroxysteroid 3-dehydrogenase
Official title: 3Alpha-hydroxysteroid 3-dehydrogenase (B-specific) (1.1.1.50)
C12Y101/0105 (3alpha-hydroxysteroid 3-dehydrogenase) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 7
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 22 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biotechnological production of diols22 Apr 2025US 12,281,343 B2Symrise AG
- 3α-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid19 Apr 2022US 11,306,343 B2PharmaZell GmbH
- Method for biocatalytic whole cell reduction of dehydrocholic acid compounds, and 7-β-hydroxysteroid dehydrogenase mutants28 Jan 2020US 10,544,441 B2PharmaZell GmbH
- 3-alpha-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid26 Nov 2019US 10,487,348 B2PharmaZell GmbH
- Dry analytical element for bile acid analysis and method of measuring bile acid4 Jun 2026US 2026/0152780 A1FUJIFILM Corporation
- High purity non-animal derived tudca12 Jun 2025US 2025/0188113 A1Sandhill One, LLC
- Biotechnological production of diols6 Jul 2023US 2023/0212616 A1Symrise AG
- Inhibition of catalytic site common to multiple 3 alpha-oxidoreductases for treatment of prostate cancer19 Aug 2021US 2021/0252115 A1
- 3-alpha-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid26 Dec 2019US 2019/0390242 A1PharmaZell GmbH
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.